From CNBC: 2024-09-24 07:00:01

Novo Nordisk’s CEO will testify before the Senate over high prices of Wegovy and Ozempic injections in the U.S. Prices soar in the U.S., with Ozempic costing nearly $969 and Wegovy almost $1,350 per month. Similar treatments in Europe cost as little as $59-$92 per month. Sanders warns demand could bankrupt U.S. health care system unless prices drop. Senate Health Committee says half of Americans using Novo Nordisk and Eli Lilly drugs could cost $411 billion per year. Medicare spent $4.6 billion on Ozempic in 2022, with other insurers implementing strict requirements to control costs. Hearing coincides with Biden administration’s efforts to lower health-care costs.



Read more at CNBC: Novo Nordisk CEO to testify at Senate over weight loss drug prices